These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
130 related items for PubMed ID: 18205296
1. Dynamic combinatorial mass spectrometry leads to metallo-beta-lactamase inhibitors. Liénard BM, Hüting R, Lassaux P, Galleni M, Frère JM, Schofield CJ. J Med Chem; 2008 Feb 14; 51(3):684-8. PubMed ID: 18205296 [Abstract] [Full Text] [Related]
2. Thiols as classical and slow-binding inhibitors of IMP-1 and other binuclear metallo-beta-lactamases. Siemann S, Clarke AJ, Viswanatha T, Dmitrienko GI. Biochemistry; 2003 Feb 18; 42(6):1673-83. PubMed ID: 12578382 [Abstract] [Full Text] [Related]
3. Structural basis for the broad-spectrum inhibition of metallo-beta-lactamases by thiols. Liénard BM, Garau G, Horsfall L, Karsisiotis AI, Damblon C, Lassaux P, Papamicael C, Roberts GC, Galleni M, Dideberg O, Frère JM, Schofield CJ. Org Biomol Chem; 2008 Jul 07; 6(13):2282-94. PubMed ID: 18563261 [Abstract] [Full Text] [Related]
4. Irreversible inhibition of metallo-beta-lactamase (IMP-1) by 3-(3-mercaptopropionylsulfanyl)propionic acid pentafluorophenyl ester. Kurosaki H, Yamaguchi Y, Higashi T, Soga K, Matsueda S, Yumoto H, Misumi S, Yamagata Y, Arakawa Y, Goto M. Angew Chem Int Ed Engl; 2005 Jun 20; 44(25):3861-4. PubMed ID: 15892033 [No Abstract] [Full Text] [Related]
5. Probing, inhibition, and crystallographic characterization of metallo-beta-lactamase (IMP-1) with fluorescent agents containing dansyl and thiol groups. Kurosaki H, Yamaguchi Y, Yasuzawa H, Jin W, Yamagata Y, Arakawa Y. ChemMedChem; 2006 Sep 20; 1(9):969-72. PubMed ID: 16937423 [No Abstract] [Full Text] [Related]
6. Mercaptophosphonate compounds as broad-spectrum inhibitors of the metallo-beta-lactamases. Lassaux P, Hamel M, Gulea M, Delbrück H, Mercuri PS, Horsfall L, Dehareng D, Kupper M, Frère JM, Hoffmann K, Galleni M, Bebrone C. J Med Chem; 2010 Jul 08; 53(13):4862-76. PubMed ID: 20527888 [Abstract] [Full Text] [Related]
7. Combined mass spectrometry and dynamic chemistry approach to identify metalloenzyme inhibitors. Liénard BM, Selevsek N, Oldham NJ, Schofield CJ. ChemMedChem; 2007 Feb 08; 2(2):175-9. PubMed ID: 17206734 [No Abstract] [Full Text] [Related]
8. Homo-cysteinyl peptide inhibitors of the L1 metallo-beta-lactamase, and SAR as determined by combinatorial library synthesis. Sun Q, Law A, Crowder MW, Geysen HM. Bioorg Med Chem Lett; 2006 Oct 01; 16(19):5169-75. PubMed ID: 16875814 [Abstract] [Full Text] [Related]
9. Inhibitors of the FEZ-1 metallo-beta-lactamase. Liénard BM, Horsfall LE, Galleni M, Frère JM, Schofield CJ. Bioorg Med Chem Lett; 2007 Feb 15; 17(4):964-8. PubMed ID: 17157014 [Abstract] [Full Text] [Related]
10. New leads of metallo-beta-lactamase inhibitors from structure-based pharmacophore design. Olsen L, Jost S, Adolph HW, Pettersson I, Hemmingsen L, Jørgensen FS. Bioorg Med Chem; 2006 Apr 15; 14(8):2627-35. PubMed ID: 16378729 [Abstract] [Full Text] [Related]
11. Overcoming resistance to beta-lactamase inhibitors: comparing sulbactam to novel inhibitors against clavulanate resistant SHV enzymes with substitutions at Ambler position 244. Thomson JM, Distler AM, Bonomo RA. Biochemistry; 2007 Oct 09; 46(40):11361-8. PubMed ID: 17848099 [Abstract] [Full Text] [Related]
12. Zinc-bound thiolate-disulfide exchange: a strategy for inhibiting metallo-beta-lactamases. Boerzel H, Koeckert M, Bu W, Spingler B, Lippard SJ. Inorg Chem; 2003 Mar 10; 42(5):1604-15. PubMed ID: 12611529 [Abstract] [Full Text] [Related]
13. 68Zn isotope exchange experiments reveal an unusual kinetic lability of the metal ions in the di-zinc form of IMP-1 metallo-beta-lactamase. Siemann S, Badiei HR, Karanassios V, Viswanatha T, Dmitrienko GI. Chem Commun (Camb); 2006 Feb 07; (5):532-4. PubMed ID: 16432573 [Abstract] [Full Text] [Related]
14. Mechanism of inactivation of beta-lactamases by novel 6-methylidene penems elucidated using electrospray ionization mass spectrometry. Tabei K, Feng X, Venkatesan AM, Abe T, Hideki U, Mansour TS, Siegel MM. J Med Chem; 2004 Jul 01; 47(14):3674-88. PubMed ID: 15214794 [Abstract] [Full Text] [Related]
15. Metal content and localization during turnover in B. cereus metallo-beta-lactamase. Llarrull LI, Tioni MF, Vila AJ. J Am Chem Soc; 2008 Nov 26; 130(47):15842-51. PubMed ID: 18980306 [Abstract] [Full Text] [Related]
17. Inhibition studies on the metallo-beta-lactamase L1 from Stenotrophomonas maltophilia. Yang KW, Crowder MW. Arch Biochem Biophys; 1999 Aug 01; 368(1):1-6. PubMed ID: 10415104 [Abstract] [Full Text] [Related]
18. Inhibitors of metallo-beta-lactamase generated from beta-lactam antibiotics. Badarau A, Llinás A, Laws AP, Damblon C, Page MI. Biochemistry; 2005 Jun 21; 44(24):8578-89. PubMed ID: 15952764 [Abstract] [Full Text] [Related]
19. Studies on ternary metallo-beta lactamase-inhibitor complexes using electrospray ionization mass spectrometry. Selevsek N, Tholey A, Heinzle E, Liénard BM, Oldham NJ, Schofield CJ, Heinz U, Adolph HW, Frère JM. J Am Soc Mass Spectrom; 2006 Jul 21; 17(7):1000-4. PubMed ID: 16713713 [Abstract] [Full Text] [Related]
20. Complexes of thiomandelate and captopril mercaptocarboxylate inhibitors to metallo-beta-lactamase by polarizable molecular mechanics. Validation on model binding sites by quantum chemistry. Antony J, Piquemal JP, Gresh N. J Comput Chem; 2005 Aug 21; 26(11):1131-47. PubMed ID: 15937993 [Abstract] [Full Text] [Related] Page: [Next] [New Search]